SecBot SecBot
DEFA14A ·Filed Jul 29, 2026

ROIV

Roivant Sciences Ltd.
NEUTRAL
Impact 3/10
Horizondays Processed3mo ago SEC0001140361-26-029956
Proxy solicitation materials
Actionable Insight • Neutral

This DEFA14A filing is a procedural proxy solicitation update with no new financial or strategic information. Monitor for the definitive proxy statement (DEF 14A) or subsequent filings for details on the matters to be voted on. The stock is unlikely to react to this filing alone.

DirectionNeutral
Confidencelow
Horizondays
Final — all horizons settled through T+60d
ROIV ▲ +13.93% at T+60d
NEUTRAL call +13.93% · α vs SPY +9.20% · entry $32.87 → $37.45
Entry = T+0 close
Jul 29, 2026
via day close
T+1d
+5.02%
call +5.02% · α +3.34%
$34.52
settled 3mo ago
T+5d
+5.26%
call +5.26% · α -0.27%
$34.60
settled 3mo ago
T+20d
+11.80%
call +11.80% · α +6.78%
$36.75
settled 2mo ago
T+60d
+13.93%
call +13.93% · α +9.20%
$37.45
settled 5d ago

Price Chart

Loading chart...

Executive Summary

Roivant Sciences filed a DEFA14A (definitive additional proxy soliciting materials) on July 29, 2026. The filing is marked as 'Soliciting Material Under 240.14a-12' and was filed by the registrant (management). No specific financial data, activist demands, or meeting details are disclosed in the filing text. The filing appears to be a routine procedural step in an ongoing proxy solicitation process, likely related to an upcoming shareholder vote, but the document content provides no material new information beyond confirming the filing type and filer identity.

Key Facts

  • Roivant Sciences filed a DEFA14A on July 29, 2026, as additional definitive proxy soliciting materials.
  • The filing is marked as 'Soliciting Material Under 240.14a-12' and was filed by the registrant (management).
  • No financial figures, activist demands, meeting date, or specific proposals are disclosed in the provided document text.
  • The filing contains only boilerplate SEC header information and no substantive content.

Financial Impact

No financial impact disclosed in the filing.

Risk Factors

  • No material risks identified from this filing; the document lacks substantive content.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
89% bullish (19 analysts)

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
DEFA14A Filing (Primary)0001140361-26-029956
Document: 0001140361-26-029956-index-headers.html0001140361-26-029956
Document: 0001140361-26-029956-index.html0001140361-26-029956
Document: 0001140361-26-029956.txt0001140361-26-029956
24 reports for ROIV
Performance horizon
67% Hit rate @ T+20 4 of 6 directional calls Went positive at some point 6 of 8 best @ T+60▲ +28.81%Mar 28, 2026
Filters
Rows
Reports for ROIV — sortable, filterable
TypeNow
Oct 27, 2026
today
SC 13G/A
NEUTRAL ★ 2/10
—awaiting T+20——
Oct 21, 2026
6d ago
8-K
BULLISH ★ 7/10
$36.80awaiting T+20—$36.54 (−0.71%)
Oct 5, 2026
21d ago
Insider Cluster
BEARISH ★ 4/10
$35.53awaiting T+20—$36.54 (−2.84%)
Sep 17, 2026
5w ago
Insider Cluster
NEUTRAL ★ 2/10
$39.77 $33.53▼ −15.69%▼ −15.89%$36.54 (−8.12%)
Sep 17, 2026
5w ago
Insider Cluster
NEUTRAL ★ 2/10
$39.77 $33.53▼ −15.69%▼ −15.89%$36.54 (−8.12%)
Sep 17, 2026
5w ago
Insider Cluster
NEUTRAL ★ 2/10
$39.77 $33.53▼ −15.69%▼ −15.89%$36.54 (−8.12%)
Sep 1, 2026
7w ago
Insider Cluster
NEUTRAL ★ 3/10
$34.18 $36.57▲ +6.99%▲ +7.32%$36.54 (+6.90%)
Aug 27, 2026
8w ago
Press Release
BULLISH ★ 8/10
$37.58 $36.13▼ −3.86%▼ −3.35%$36.54 (−2.77%)
Aug 27, 2026
8w ago
Press Release
BULLISH ★ 8/10
$37.58 $36.13▼ −3.86%▼ −3.35%$36.54 (−2.77%)
Aug 26, 2026
8w ago
Press Release
BULLISH ★ 6/10
$36.75 $38.99▲ +6.10%▲ +4.89%$36.54 (−0.57%)
Showing 10 of 24

US Market Status

Market Closed — Opens Wed (15h 47m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jul 29, 2026